研究者
J-GLOBAL ID：202301008373152896   更新日: 2024年11月17日

水野 伸匡

Mizuno Nobumasa
競争的資金等の研究課題 (3件)：
  • 2019 - 2023 定量ctDNA解析の切除可能境界膵癌に対する術前治療の効果と手術適応判定への応用
  • 2014 - 2018 膵神経内分泌腫瘍における新たな分子生物学的分類と個別化治療への応用に関する研究
  • 2008 - 2010 慢性膵炎発症・進展における膜蛋白の細胞内局在異常の解明
論文 (225件)：
  • Shuichi Mitsunaga, Masafumi Ikeda, Shogo Nomura, Chigusa Morizane, Akiko Todaka, Naoto Yamamoto, Ken Kamata, Hiroo Yanagibashi, Nobumasa Mizuno, Yasuyuki Kawamoto, et al. 5-Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S-1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1). Journal of hepato-biliary-pancreatic sciences. 2024
  • Kentaro Sudo, Yoshiaki Nakamura, Makoto Ueno, Masayuki Furukawa, Nobumasa Mizuno, Yasuyuki Kawamoto, Naohiro Okano, Kumiko Umemoto, Akinori Asagi, Masato Ozaka, et al. Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer. British journal of cancer. 2024
  • Takamichi Kuwahara, Kazuo Hara, Nobumasa Mizuno, Shin Haba, Nozomi Okuno, Toshitaka Fukui, Minako Urata, Yoshitaro Yamamoto. Current status of artificial intelligence analysis for the treatment of pancreaticobiliary diseases using endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography. DEN open. 2024. 4. 1. e267
  • Sho Ishikawa, Kazuo Hara, Nozomi Okuno, Nobumasa Mizuno, Shin Haba, Takamichi Kuwahara, Yasuhiro Kuraishi, Takafumi Yanaidani, Masanori Yamada, Tsukasa Yasuda, et al. Safety and efficacy of novel oblique-viewing scope for B2-endoscopic ultrasound-guided hepaticogastrostomy. Clinical endoscopy. 2024
  • Akiko Todaka, Mitsuhito Sasaki, Hideki Ueno, Takuma Goto, Gou Murohisa, Nobumasa Mizuno, Masato Ozaka, Satoshi Kobayashi, Kazuhiro Uesugi, Noritoshi Kobayashi, et al. FOLFIRINOX in Pancreatic Cancer: Risk Factors for Febrile Neutropenia and Severe Neutropenia - Nationwide Study Analysis. Anticancer research. 2023. 43. 9. 4115-4123
もっと見る
MISC (80件)：
  • Satoshi Kobayashi, Makoto Ueno, Gakuto Ogawa, Akira Fukutomi, Masafumi Ikeda, Takuji Okusaka, Tosiya Sato, Yoshinori Ito, Tomohiro Kadota, Tatsuya Ioka, et al. Impact of renal function on the efficacy and safety of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer. JOURNAL OF CLINICAL ONCOLOGY. 2019. 37. 4
  • Makoto Ueno, Chigusa Morizane, Takuji Okusaka, Gakuto Ogawa, Yuya Sato, Masafumi Ikeda, Masato Ozaka, Kazuya Sugimori, Akira Fukutomi, Hiroki Hara, et al. The influence of renal function on gemcitabine-based chemotherapy for advanced biliary tract cancer: An exploratory subgroup analysis of JCOG1113. JOURNAL OF CLINICAL ONCOLOGY. 2019. 37. 4
  • Ikuhiro Yamada, Chigusa Morizane, Takuji Okusaka, Gakuto Ogawa, Yuya Sato, Makoto Ueno, Masafumi Ikeda, Kazuya Sugimori, Akira Fukutomi, Satoshi Shimizu, et al. The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: An exploratory subgroup analysis of JCOG1113. JOURNAL OF CLINICAL ONCOLOGY. 2019. 37. 4
  • 栗田 裕介, 肱岡 範, 水野 伸匡, 奥野 のぞみ, 桑原 崇通, 田近 正洋, 田中 努, 石原 誠, 平山 裕, 大西 祥代, et al. 【膵神経内分泌腫瘍診療の最前線】 切除不能低分化型膵神経内分泌癌(panNEC-G3)の特徴と薬物療法. 胆と膵. 2017. 38. 12. 1403-1411
  • Masafumi Ikeda, Takashi Sasaki, Chigusa Morizane, Nobumasa Mizuno, Fumio Nagashima, Satoshi Shimizu, Nozomi Hayata, Hiroki Ikezawa, Takuya Suzuki, Ryo Nakajima, et al. A Phase II Study of Lenvatinib Monotherapy as Second-Line Treatment in Unresectable Biliary Tract Cancer: Primary Analysis Results. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. 2017. 13. 115-115
もっと見る
※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る

TOP

BOTTOM